| GILEAD SCIENCES DL-,001 |
| USA |
| Gesundheit |
| US3755581036 / 885823 |
| GIS (Frankfurt) / GILD (NASDAQ) |
| FRA:GIS, ETR:GIS, GIS:GR, NASDAQ:GILD |
| https://www.gilead.com/ |
|
Gilead Sciences Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious and life-threatening diseases. Its current business centers on virology, oncology, and inflammation, with a particularly..
>Volltext.. |
| 172716.84 Mio. EUR |
| 191374.12 Mio. EUR |
| 27265.83 Mio. EUR |
| 13092.85 Mio. EUR |
| -2892.26 Mio. EUR |
| -2.32 EUR |
| 23429.12 Mio. EUR |
| 2837.81 Mio. EUR |
| 12097.52 Mio. EUR |
| 0.44 |
| 9.39% |
| -152.95% |
| 2.8 EUR |
| 2.08% |
| 2.09% |
| 15.09.26 - 0.710366€ 15.06.26 - 0.707578€ >weitere anzeigen... |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.817.125 Euro. |
| GILEAD, REMDESIVIR |
| 24.10.26 |
|
||||
|